Labelling and packaging
The regulation of medicines and medical devices extends to how they are labelled and packaged. The rules can be complex, depending on the product.
-
Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
If you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.
-
Recall of JSHealth Vitamins listed medicine Detox + Debloat.
-
More medicines begin transition to sole ingredient names soon
The dual labelling period for some medicine ingredients is ending on 30 April 2025. -
Updates to requirements and guidance for labels of injectable medicines
Find out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors. -
Buy and use paracetamol safely
We know that paracetamol is safe and effective for most people when taken at the recommended dose.
-
Regulation impact statement: General requirements for labels for medicines